The company expects that while vaccines will be an essential component of future dengue and malaria prevention and control efforts, immunization cannot succeed as a silver bullet solution for either disease.
Scientists have figured out all the steps to make morphine and similar painkillers without using...
The hope is that this standard can be used among the scientific community to see how well their...
These companies are having an interesting year so far.
Standard versions of this screening process would have only been able to pinpoint ovarian cancer in less than half of this group.
GlaxoSmithKline and the University of North Carolina Chapel Hill are teaming up to run this operation.
It has been hailed as the equivalent of Google Maps for the human body by The New York Times, and now the award-winning mobile-friendly platform BioDigital Human is looking to change the way healthcare information is shared, consumed and understood.
Researchers say a new epilepsy drug holds promise as a treatment for Alzheimer's disease.
Watson, the supercomputer seen on Jeopardy, will play an important role in this partnership.
Dying patients sometimes seek emergency access to experimental medicines, desperate for a last-chance treatment even if there's little proof it could help. Now drug giant Johnson & Johnson is taking an unusual step, turning to independent bioethicists for advice on when to say yes or no.
Disease-modifying treatments and novel symptomatic therapies with innovative mechanisms of action will enter the arena during the forecast period and become routinely used in care.
A new treatment for melanoma could be on the horizon. The authors of a new study report that they found high levels of an enzyme in melanoma samples that they believe is a potential drug target.
Lung cancer patients who used statins in the year prior to a lung cancer diagnosis or after a lung cancer diagnosis had a reduction in the risk of death from the disease, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.
Only 34 out of 133 countries participating in the recent survey of countries in the six WHO regions have a comprehensive national plan to fight resistance to antibiotics and other antimicrobial medicines.
An analysis of Genocea Biosciences’ investigational genital herpes (GH) vaccine, GEN-003.
The widely held belief that depression is caused by low levels of serotonin and that certain antidepressants raise the levels of this neurotransmitter, is a myth, according to a psychiatrist in an editorial article in The BMJ this week.
The U.S. Department of Agriculture is working on a vaccine to counter a deadly strain of bird flu, as losses to poultry producers mount.
The future growth of the non-vascular stent market by 2021 will be slower in the US than almost every other major market.
This method is delivering some promising results in early trials.
Here are the winners of the INTERPHEX Exhibitor Awards for 2015.
Access to high-quality medicine is a basic human right, but more than four billion people live in countries where many medications are substandard or fake.
One of the main sessions at this year’s Experimental Biology Conference in Boston was the Tang Prize Award lecture.
A single cell type in the skin of mice is a major contributor to scarring after wound healing or radiation damage, and facilitates the growth of melanoma. Blocking the cell’s activity in humans may be possible with currently approved drugs.
Research suggests strategy to prevent relapse after therapies targeting tumor blood vessels.
A wearable device that emits low-level electrical fields can slow the progression of glioblastoma, the deadliest form of brain cancer, and extend patients’ lifespans.
French biopharmaceutical company DBV Technologies moves closer to bringing its peanut allergy patch to market, receiving Breakthrough Therapy Designation from the U.S. Food and Drug Administration as it prepares to launch its Phase 3 trial.
Memory and as well as connections between brain cells were restored in mice with a model of Alzheimer’s given an experimental cancer drug.
With this award, Stanford has received a total of around $297 million from CIRM.
- Page 1